EMD Serono Canada provides innovative drug therapies that address unmet medical needs in the areas of neurodegenerative diseases,
fertility and endocrinology.
We help people better understand and manage their disease through relevant and user-friendly education resources and a dedicated
patient support team.
EMD Serono Canada, is founded upon the proud heritage of Merck KGaA, Germany, and Serono International, Switzerland. Merck
Serono is the division of Merck KGaA for innovative small molecules and biopharmaceuticals. In the United States and Canada,
the division operates as EMD Serono.
To learn more about the company's business outside of Canada, please visit the
Merck Serono website.